98 related articles for article (PubMed ID: 8587398)
21. Agonist-dependent inhibition by peptide and nonpeptide endothelin receptor antagonists in the rabbit isolated pulmonary artery.
Beck GR; Douglas SA; Elliott JD; Ohlstein EH
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S385-8. PubMed ID: 8587422
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of a novel endothelin receptor that binds both ETA- and ETB-selective ligands.
Nambi P; Pullen M; Kincaid J; Nuthulaganti P; Aiyar N; Brooks DP; Gellai M; Kumar C
Mol Pharmacol; 1997 Oct; 52(4):582-9. PubMed ID: 9380020
[TBL] [Abstract][Full Text] [Related]
23. Pharmacologic evidence for the presence of three functional endothelin receptor subtypes in rabbit saphenous vein.
Douglas SA; Beck GR; Elliott JD; Ohlstein EH
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S163-8. PubMed ID: 8587352
[TBL] [Abstract][Full Text] [Related]
24. Characterization of 125I-endothelin-1 binding to rat and rabbit renal microvasculature.
Edwards RM; Trizna W
J Pharmacol Exp Ther; 1995 Sep; 274(3):1084-9. PubMed ID: 7562473
[TBL] [Abstract][Full Text] [Related]
25. Endothelin-1-evoked calcium transients in UMR-106 osteoblastic osteosarcoma cells are mediated through endothelin-A and endothelin-B receptors.
Semler DE; Ohlstein EH; Nambi P; Slater C; Stern PH
J Pharmacol Exp Ther; 1995 Mar; 272(3):1052-8. PubMed ID: 7891315
[TBL] [Abstract][Full Text] [Related]
26. EndothelinB receptor-mediated contraction of human and rat pulmonary resistance arteries and the effect of pulmonary hypertension on endothelin responses in the rat.
McCulloch KM; MacLean MR
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S169-76. PubMed ID: 8587353
[TBL] [Abstract][Full Text] [Related]
27. Effect of endothelin antagonists with or without BQ 788 on ET-1 responses in pithed rats.
Sargent CA; Brazdil R; Flynn DA; Brown TJ; Roach AG
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S216-8. PubMed ID: 8587367
[TBL] [Abstract][Full Text] [Related]
28. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat.
Gellai M; Fletcher T; Pullen M; Nambi P
Am J Physiol; 1996 Jul; 271(1 Pt 2):R254-61. PubMed ID: 8760228
[TBL] [Abstract][Full Text] [Related]
29. Binding of 125I-endothelin-1 and 125I-endothelin-3 in rabbit saphenous vein: evidence for an atypical ET binding component.
Liu EC; Monshizadegan H; Chao CC; Lynch J; Fisher SM; Rose PM; Webb ML
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S132-5. PubMed ID: 7509924
[TBL] [Abstract][Full Text] [Related]
30. Receptor-mediated effects of endothelin on the L-type Ca++ current in ventricular cardiomyocytes.
Kelso EJ; Spiers JP; McDermott BJ; Scholfield CN; Silke B
J Pharmacol Exp Ther; 1998 Aug; 286(2):662-9. PubMed ID: 9694918
[TBL] [Abstract][Full Text] [Related]
31. Characterization of endothelin receptors in mesangial cells: evidence for two functionally distinct endothelin binding sites.
Simonson MS; Rooney A
Mol Pharmacol; 1994 Jul; 46(1):41-50. PubMed ID: 8058055
[TBL] [Abstract][Full Text] [Related]
32. Development of endothelin receptors in perinatal rabbit pulmonary resistance arteries.
Docherty C; MacLean MR
Br J Pharmacol; 1998 Jul; 124(6):1165-74. PubMed ID: 9720787
[TBL] [Abstract][Full Text] [Related]
33. Characterization of endothelin receptors mediating mechanical responses to the endothelins in the isolated stomach strip of the rat.
Allcock GH; Battistini B; Fournier A; Warner TD; Vane JR
J Pharmacol Exp Ther; 1995 Oct; 275(1):120-6. PubMed ID: 7562539
[TBL] [Abstract][Full Text] [Related]
34. Characterization of endothelin receptor subtypes in isolated rat renal preglomerular microvessels.
De León H; Garcia R
Regul Pept; 1995 Dec; 60(1):1-8. PubMed ID: 8747779
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the contractile effects and binding kinetics of endothelin-1 and sarafotoxin S6b in rat isolated renal artery.
Devadason PS; Henry PJ
Br J Pharmacol; 1997 May; 121(2):253-63. PubMed ID: 9154335
[TBL] [Abstract][Full Text] [Related]
36. Are there different ETB receptors mediating constriction and relaxation?
Clozel M; Gray GA
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S262-4. PubMed ID: 8587383
[TBL] [Abstract][Full Text] [Related]
37. Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues.
Davenport AP; Kuc RE; Ashby MJ; Patt WC; Doherty AM
Br J Pharmacol; 1998 Jan; 123(2):223-30. PubMed ID: 9489609
[TBL] [Abstract][Full Text] [Related]
38. Hyperresponsiveness to ET-1 after treatment with a mixture of ETA and ETB receptor antagonists in the rabbit in vivo and in vitro.
D'Orléans-Juste P; Yano M; Maurice MC; Gratton JP
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S369-72. PubMed ID: 8587417
[TBL] [Abstract][Full Text] [Related]
39. Endothelin receptor subtypes in resistance arteries from humans and rats.
Deng LY; Li JS; Schiffrin EL
Cardiovasc Res; 1995 Apr; 29(4):532-5. PubMed ID: 7796447
[TBL] [Abstract][Full Text] [Related]
40. Species differences in the binding characteristics of [125I]IRL-1620, a potent agonist specific for endothelin-B receptors.
Nambi P; Pullen M; Spielman W
J Pharmacol Exp Ther; 1994 Jan; 268(1):202-7. PubMed ID: 8301559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
